Late-stage trials show AstraZeneca-Oxford vaccine is up to 90% effective – With insights from The Wall Street Journal

The AstraZeneca-Oxford vaccine ‘was as much as 90% effective in preventing infection without serious side effects in large clinical trials.’

The AstraZeneca-Oxford vaccine 'was as much as 90% effective in preventing infection without serious side effects in large clinical trials.'

This article is exclusive to Biznews Premium. Members please login here. Not yet subscribed? Taste before you eat by signing up here for a half price 30 day trial (card details required).